Skip to content

Patient-Centered NeuroRehabilitation (PCN)

Patient-Centered NeuroRehabilitation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03036319
Acronym
PCN
Enrollment
500
Registered
2017-01-30
Start date
2016-06-30
Completion date
2027-11-30
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Deficit

Brief summary

As individuals grow older, a number of factors can reduce our cognitive (or thinking) abilities such as normal aging, neurodegenerative diseases, and cardiovascular disease. This study will evaluate whether cognitive rehabilitation and transcranial electrical stimulation (TES) can improve cognitive abilities. Cognitive rehabilitation refers to methods that are used to improve tasks people have trouble doing in everyday life. Transcranial electrical stimulation uses small amounts of electricity to try to alter brain functioning. These approaches may help improve cognitive abilities like attention, learning, memory, finding words, and problem solving as well as everyday functioning. The goal of this study is to identify how to best use these methods, either alone or in combination.

Detailed description

The primary objective of this study is to evaluate the feasibility of a neurorehabilitation treatment tailored to individual patient needs, with the ultimate goal of maximizing cognitive and real-world functioning for older adults with cognitive aging, mild cognitive impairment (MCI), neurodegenerative, or other neurological diseases/conditions. Transcranial electrical stimulation (TES) is a non-invasive, neurorehabilitation procedure in which a weak electric current is passed between electrodes that are placed on the scalp with the intention of modulating excitability of the underlying brain regions. Because the field of TES is relatively young, rapidly evolving, and primarily focused on cognitive neuroscience with healthy individuals, there is a clear need for well-conceptualized and conducted clinical research. The current protocol is intentionally broad with respect to both methodology and patient characteristics in order to tailor potential TES interventions to individual patients or small samples. The current protocol utilizes various forms of TES including transcranial direct current stimulation (tDCS), alternating current stimulation (tACS), and random noise stimulation (tRNS) and sham stimulation in older adults. As this is a cross-over design, some participants may receive active (or real) TES and/or sham TES conditions.This includes head to head comparisons of the different forms of TES. Additionally, TES could be performed in conjunction with cognitively-based intervention since this may enhance the neuroplastic response of the targeted brain region(s) while at the same time shaping/optimizing the pathways that are engaged by cognitively-based interventions. This broad approach is important since etiological differences in cognitive impairment may necessitate distinct interventions.

Interventions

DEVICEActive tDCS

Participants will receive active tDCS at up to 4mA per electrode for up to 40 minutes for up to 260 sessions.

DEVICESham tDCS

Participants will receive sham tDCS for up to 260 sessions

BEHAVIORALCognitively based intervention

Participants may receive a cognitively based intervention that targets the particular cognitive and/or functional abilities of interest. This includes methods of cognitive training, cognitive remediation, and cognitive rehabilitation for up to 260 sessions

Participants will receive active transcranial alternating current stimulation at up to 4mA per electrode for up to 40 minutes for up to 260 sessions

DEVICESham tACS

Participants will receive sham transcranial alternating current stimulation for up to 260 sessions

Participants will receive active transcranial random noise stimulation at up to 4mA per electrode for up to 40 minutes for up to 260 sessions

DEVICESham tRNS

Participants will receive sham transcranial random noise stimulation for up to 260 sessions

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Given the nature of this study, the participant, care provider, investigator, and/or outcome assessors may or may not be blinded to the treatment condition.

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Individuals who have reported cognitive dysfunction and cognitively intact participants. 2. Participants will be age 50 or older

Exclusion criteria

1. A history of epilepsy 2. Sensory or motor impairments that limit the ability to take part in the study 3. Current alcohol or drug abuse/dependence 4. Those who are currently pregnant or may become pregnant during the duration of the study (if there is a question of pregnancy, pregnancy tests will be available for participants at no charge) Those who are being evaluated for TES methodology will also be excluded for 1) metallic or electronic implant 2) skull plates or other cranial implants that affect TES

Design outcomes

Primary

MeasureTime frameDescription
TES side effect questionnaireImmediately following TES (<15 minutes)Side effect questionnaire that asks participants to rate the severity of potential TES related side effects

Countries

United States

Contacts

Primary ContactKayla Rinna, M.S.
krinna@med.umich.edu734-936-7739
Backup ContactEileen Robinson, RN, MPH
robinsoe@med.umich.edu734-763-1356

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026